DCB Open Innovation Challenge 2024: Meet our Top 20!

DCB Open Innovation Challenge 2024: Meet our Top 20!

DCB Open Innovation Challenge 2024: Meet our Top 20!

The DCB Open Innovation Challenge 2024 is entering its next round! From all 100 submitted ideas, our evaluation committee has now selected the Top 20.

Meet our Top 20!

Following a meticulous evaluation of incredible 100 submissions for our Open Innovation Challenge, our team has selected the top 20 ideas to advance to the next phase.

We are pleased to announce the innovative concepts that have successfully progressed. This year’s submissions have surpassed expectations, and we eagerly anticipate mentoring with these 20 outstanding innovators. Among them, 2 from the US and 4 from around the globe will later be chosen as finalists, earning the opportunity to participate in our bootcamp and competing for the win at our prestigious award ceremony.

As we embark on this journey, we invite you to explore the detailed profiles of the top 20 innovators in the attached PDF. Let us collectively celebrate innovation and collaboration as we move forward!

Downloads

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland

DCB featured in Nature Portfolio: “Cutting-edge diabetes technology to make lives easier”

DCB featured in Nature Portfolio: “Cutting-edge diabetes technology to make lives easier”

DCB featured in Nature Portfolio: “Cutting-edge diabetes technology to make lives easier”

DCB is thrilled to be featured in the Nature Portfolio Spotlight on Switzerland. The article “Cutting-edge diabetes technology to make lives easier” dives into our work at DCB and outlines significant advancements in diabetes management.

Cutting-edge diabetes technology to make lives easier

The renowned Nature Portfolio has issued a Spotlight on Switzerland with the motto: “Switzerland has enjoyed a warm relationship with the rest of Europe for decades – but how has that influenced the research done in the country?”

DCB is thrilled to be featured in this Spotlight, shining a light on diabetes technology research and innovation.

Our assistant professors José García-Tirado and Lilian Witthauer, as well as our scientific program manager Martina Rothenbühler were interviewed, providing insights into their work at DCB and the development of technologies such as the artificial pancreas, which promises to transform the daily lives of people with diabetes by simplifying insulin management.

“Our mission is to support diabetes research and technological advancement. We’re building bridges between research and startups, industry and other stakeholders.”

– Martina Rothenbühler, DCB

Read the article now to dive deeper into our work and see how innovative technologies are shaping the future of diabetes management.

More recent news

Sign up for our newsletter and stay up to date.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Switzerland